AVP BioPharma Consult ApS: Financial statements 2024
CVR: 37770426
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,169,184 and a net result of DKK 237,789 compared with DKK 106,199 the year before. That is an increase of 15.9% compared with the year before. Equity in the 2024 report amounted to DKK 323,077. The solvency ratio was 64%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,169,184
- Profit/Loss
- DKK 237,789
- Equity
- DKK 323,077
- Total Assets
- DKK 504,450
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.2M | 238K | 323K | 1 |
| 2023 | - | 1M | 106K | 225K | 1 |
| 2022 | - | 1.1M | 148K | 294K | 1 |
| 2021 | - | 1.2M | 261K | 346K | 1 |
| 2020 | - | 1.1M | 190K | 295K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
AVP BioPharma Consult ApS has published its annual report for 2023. Gross profit came to DKK 1,008,640, and the net result was DKK 106,199.
About AVP BioPharma Consult ApS
AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.
